Literature DB >> 15767441

Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production.

Nazmul Ahsan1, Teru Kanda, Kazuo Nagashima, Kenzo Takada.   

Abstract

The Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1), which is critical for EBV-induced B-cell transformation, is also abundantly expressed during the lytic cycle of viral replication. However, the biological significance of this strong LMP1 induction remains unknown. We engineered a bacterial artificial chromosome clone containing the entire genome of Akata strain EBV to specifically disrupt the LMP1 gene. Akata cell clones harboring the episomes of LMP1-deleted EBV were established, and the effect of LMP1 loss on virus production was investigated. We found that the degree of viral DNA amplification and the expression levels of viral late gene products were unaffected by LMP1 loss, demonstrating that the LMP1-deleted EBV entered the lytic replication cycle as efficiently as the wild-type counterpart. This was confirmed by our electron microscopic observation that nucleocapsid formation inside nuclei occurred even in the absence of LMP1. By contrast, loss of LMP1 severely impaired virus release into culture supernatants, resulting in poor infection efficiency. The expression of truncated LMP1 in Akata cells harboring LMP1-deleted EBV rescued the virus release into the culture supernatant and the infectivity, and full-length LMP1 partially rescued the infectivity. These results indicate that inducible expression of LMP1 during the viral lytic cycle plays a critical role in virus production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767441      PMCID: PMC1061545          DOI: 10.1128/JVI.79.7.4415-4424.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.

Authors:  M Rowe; H S Evans; L S Young; K Hennessy; E Kieff; A B Rickinson
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

2.  Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination.

Authors:  G Lee; I Saito
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

3.  The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels.

Authors:  W Hammerschmidt; B Sugden; V R Baichwal
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 4.  An intricate route to immortality.

Authors:  B Sugden
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

5.  The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation.

Authors:  V R Baichwal; B Sugden
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

6.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Authors:  D Wang; D Liebowitz; F Wang; C Gregory; A Rickinson; R Larson; T Springer; E Kieff
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines.

Authors:  S Modrow; H Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).

Authors:  G R Nemerow; R A Houghten; M D Moore; N R Cooper
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

9.  The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.

Authors:  H Boos; R Berger; C Kuklik-Roos; T Iftner; N Mueller-Lantzsch
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

View more
  21 in total

1.  Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.

Authors:  Nirojini Sivachandran; Xueqi Wang; Lori Frappier
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

2.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.

Authors:  Renfeng Li; Jian Zhu; Zhi Xie; Gangling Liao; Jianyong Liu; Mei-Ru Chen; Shaohui Hu; Crystal Woodard; Jimmy Lin; Sean D Taverna; Prashant Desai; Richard F Ambinder; Gary S Hayward; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

4.  Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Authors:  Rachel M Temple; Junjia Zhu; Lynn Budgeon; Neil David Christensen; Craig Meyers; Clare E Sample
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

5.  Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification.

Authors:  Cheng-Wei Li; Bo-Ren Jheng; Bor-Sen Chen
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

6.  LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Authors:  Gretchen L Bentz; Charles Randall Moss; Christopher B Whitehurst; Cary A Moody; Joseph S Pagano
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

7.  Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.

Authors:  Seiji Maruo; Yi Wu; Satoko Ishikawa; Teru Kanda; Dai Iwakiri; Kenzo Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

8.  Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.

Authors:  Dhananjay M Nawandar; Makoto Ohashi; Reza Djavadian; Elizabeth Barlow; Kathleen Makielski; Ahmed Ali; Denis Lee; Paul F Lambert; Eric Johannsen; Shannon C Kenney
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

9.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

10.  Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.

Authors:  Giulia Matusali; Giuseppe Arena; Alessandra De Leo; Livia Di Renzo; Elena Mattia
Journal:  Mol Cancer       Date:  2009-03-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.